202865-80-3

Basic information

• Product Name: 2-(4'-BROMO-2'-FLUOROPHENOXY)PROPANE
• Synonyms: 2-(4'-BROMO-2'-FLUOROPHENOXY)PROPANE;2-(4-BROMO-2-FLUOROPHENOXY)PROPANE;4-Bromo-2-fluoro-1-isopropoxyBenzene;2-(4-Bromo-2-fluorophenoxy)propane 98%;2-(4-Bromo-2-fluorophenoxy)propane98%;4-bromo-2-fluoro-1-propan-2-yloxybenzene
• CAS NO: 202865-80-3
• Molecular Formula: C₉H₁₀BrFO
• Molecular Weight: 233.08
• Product Categories: Anisoles, Alkyloxy Compounds & Phenylacetates;Bromine Compounds;Fluorine Compounds
• Mol File: 202865-80-3.mol

Chemical Properties

• Boiling Point: 244.6°C at 760 mmHg
• Flash Point: 124.4°C
• Appearance: /
• Density: 1.393g/cm³
• Vapor Pressure: 0.0469mmHg at 25°C
• Refractive Index: 1.507
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 2-(4'-BROMO-2'-FLUOROPHENOXY)PROPANE(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(4'-BROMO-2'-FLUOROPHENOXY)PROPANE(202865-80-3)
• EPA Substance Registry System: 2-(4'-BROMO-2'-FLUOROPHENOXY)PROPANE(202865-80-3)

Safety Data

• Hazard Codes: Xi
• Statements: 36/37/38
• Safety Statements: 26-36/37/39
• Hazardous Substances Data: 202865-80-3(Hazardous Substances Data)

Usage

Uses

Used in Synthetic Chemistry:
2-(4'-BROMO-2'-FLUOROPHENOXY)PROPANE is used as a chemical intermediate for the construction of more complex molecules. Its reactivity, introduced by the bromine atom, enables it to participate in various organic reactions, making it a valuable component in the synthesis process.
Used in Pharmaceutical Industry:
2-(4'-BROMO-2'-FLUOROPHENOXY)PROPANE is used as a building block for the development of new pharmaceutical compounds. The phenol group in its structure contributes to the overall pharmacological properties, which can be harnessed for the creation of potential drug candidates.
Used in Material Science:
2-(4'-BROMO-2'-FLUOROPHENOXY)PROPANE is used as a component in the development of new materials. The stability and resistance to degradation, enhanced by the fluorine atom, make it a suitable candidate for applications where durability and chemical resistance are required.
It is important to handle 2-(4'-BROMO-2'-FLUOROPHENOXY)PROPANE with care due to its reactive nature and potential health hazards if mishandled.

InChI:InChI=1/C9H10BrFO/c1-6(2)12-9-4-3-7(10)5-8(9)11/h3-6H,1-2H3

Upstream product

• 75-30-9 2-iodo-propane 
• 2105-94-4 4-bromo-2-fluorophenol 
• 121219-03-2 4-bromo-3-fluorophenol 
• 67-63-0 isopropyl alcohol 

Downstream Products

• 1532533-67-7 TGR-1202 
• 1532533-69-9 (R)-2-(1-(4-amino-3-(3-fluoro-4-isopropoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)ethyl)-6-fluoro-3-(3-fluorophenyl)-4H-chromen-4-one 
• 1359815-31-8 3-t-butyl-1-(4-chlorobenzyl)-5-(3-fluoro-4-isopropoxyphenylamino)pyrazole 
• 1359815-46-5 5-ethyl-2-(3-fluoro-4-isopropoxyphenylamino)-3-(4-methylphenoxy)pyrazine 
• 1408087-64-8 3-(3-fluoro-4-isopropoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine 
• 1408087-20-6 2-(1-(4-amino-3-(3-fluoro-4-isopropoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)ethyl)-3-(3-fluorophenyl)-5-morpholino-4H-chromen-4-one 
• 1408085-85-7 2-(1-(4-amino-3-(3-fluoro-4-isopropoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)ethyl)-5-fluoro-3-(3-fluorophenyl)-4H-chromen-4-one 4-methylbenzenesulfonate 
• 1408085-14-2 2-(1-(4-amino-3-(3-fluoro-4-isopropoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)ethyl)-5-fluoro-3-(3-fluorophenyl)-4H-chromen-4-one 
• 1408085-09-5 2-((4-amino-3-(3-fluoro-4-isopropoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)methyl)-5-fluoro-3-(3-fluorophenyl)-4H-chromen-4-one 
• 1408085-07-3 2-((4-Amino-3-(3-fluoro-4-isopropoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)methyl)-3-(3-fluorophenyl)-5-methoxy-4H-chromen-4-one 
• 1350426-06-0 2-(3-fluoro-4-isopropoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
• 749933-69-5 1-cyclopentyl-3-(3-fluoro-4-isopropoxyphenyl)propan-1-one 

Relevant articles and documents

PYRAZOLOPYRIMIDINE DERIVATIVE AND USE THEREOF AS PI3K INHIBITOR

The present invention discloses a series of pyrazolopyrimidine derivatives and use thereof in preparing a medicament for treating a disease related to PI3K, and in particular, discloses a derivative compound of formula (I), a tautomer thereof or a pharmaceutically acceptable composition thereof.

Combination of Anti-CD20 Antibody and PI3 Kinase Selective Inhibitor

Highly effective combinations of a compound of formula A (a PI3Kδ selective inhibitor) and anti-CD20 antibodies are provided herein for the treatment and amelioration of PI3Kδ and/or CD20 mediated diseases and disorders. In particular, the combination can

SELECTIVE PI3K DELTA INHIBITORS

The present invention relates to selective inhibitors of PI3K delta protein kinases having a lH-pyrazolo[3,4-d]pyrimidine ring system, methods of preparing them, pharmaceutical compositions containing them and methods of treatment and/or prevention of kin

NOVEL COMPOUNDS AS MODULATORS OF PROTEIN KINASES

The present invention provides PI3K protein kinase modulators, methods of preparing them, pharmaceutical compositions containing them and methods of treatment, prevention and/or amelioration of kinase mediated diseases or disorders with them.

NOVEL COMPOUNDS AS MODULATORS OF PROTEIN KINASES

The present invention provides PI3K protein kinase modulators, methods of preparing them, pharmaceutical compositions containing them and methods of treatment, prevention and/or amelioration of kinase mediated diseases or disorders with them.

NOVEL 3,5-DISUBSTITUED-3H-IMIDAZO[4,5-B]PYRIDINE AND 3,5- DISUBSTITUED -3H-[1,2,3]TRIAZOLO[4,5-B] PYRIDINE COMPOUNDS AS MODULATORS OF PROTEIN KINASES

The present invention provides, inter alia, compounds of formula ΙΑ,ΙΙΑ and III as protein kinase modulators, methods of preparing them, pharmaceutical compositions containing them and methods of treatment, prevention and/or amelioration of kinase mediated diseases or disorders with them.

NOVEL 3,5-DISUBSTITUTED-3H-IMIDAZO[4,5-B]PYRIDINE AND 3,5- DISUBSTITUTED -3H-[1,2,3]TRIAZOLO[4,5-B] PYRIDINE COMPOUNDS AS MODULATORS OF PROTEIN KINASES

The present invention provides, inter alia, compounds of formula I as protein kinase modulators, methods of preparing them, pharmaceutical compositions containing them and methods of treatment, prevention and/or amelioration of kinase mediated diseases or disorders with them.

(3,4-DISUBSTITUTED)PROPANOIC CARBOXYLATES AS S1P (EDG) RECEPTOR AGONISTS

The present invention encompasses compounds of Formula A: A as well as the pharmaceutically acceptable salts thereof. The compounds are S1P1/Edg1 receptor agonists and thus have immunosuppressive, anti-inflammatory and hemostatic activities by modulating leukocyte trafficking, sequestering lymphocytes in secondary lymphoid tissues, and enhancing vascular integrity. The invention is also directed to pharmaceutical compositions containing such compounds and methods of treatment or prevention.